Insider trading

Period: 120 months Stock: VIR + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

344 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

344 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

344 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

344 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
344 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
344 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

344 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
13 Oct 2020
Virgin Herbert EVP, Research & CSO
Sold, plan not stated
$239.24K 5,560 at 43.03
19.0%
7 Oct 2020
Pang Phillip Chief Medical Officer
Sold, plan not stated 2×
$521.80K 12,500 at 41.74
29.6%
1 Oct 2020
Parrish Jay Chief Business Officer
Sold, plan not stated
$241.34K 6,945 at 34.75
3.0%
29 Sep 2020
Virgin Herbert EVP, Research & CSO
Sold, plan not stated
$133.38K 3,510 at 38.00
12.9%
22 Sep 2020
Virgin Herbert EVP, Research & CSO
Sold, plan not stated
$120.64K 3,805 at 31.71
16.0%
16 Sep 2020
Pang Phillip Chief Medical Officer
Sold, plan not stated 2×
$398.69K 12,500 at 31.90
29.6%
8 Sep 2020
Virgin Herbert EVP, Research & CSO
Sold, plan not stated 2×
$114.10K 3,805 at 29.99
16.0%
2 Sep 2020
Pang Phillip Chief Medical Officer
Sold, plan not stated 2×
$411.16K 12,500 at 32.89
29.6%
1 Sep 2020
Parrish Jay Chief Business Officer
Sold, plan not stated
$271.80K 6,943 at 39.15
3.0%
25 Aug 2020
Virgin Herbert EVP, Research & CSO
Sold, plan not stated
$238.63K 5,560 at 42.92
21.8%
19 Aug 2020
Pang Phillip Chief Medical Officer
Sold, plan not stated 2×
$636.86K 12,500 at 50.95
29.6%
11 Aug 2020
Virgin Herbert EVP, Research & CSO
Sold, plan not stated
$403.56K 7,900 at 51.08
100%
Sold half or more
5 Aug 2020
Pang Phillip Chief Medical Officer
Sold, plan not stated 2×
$636.22K 12,500 at 50.90
44.2%
3 Aug 2020
Parrish Jay Chief Business Officer
Sold, plan not stated
$529.40K 11,110 at 47.65
4.8%
28 Jul 2020
Virgin Herbert EVP, Research & CSO
Sold, plan not stated
$379.09K 7,900 at 47.99
100%
Sold half or more
15 Jul 2020
Pang Phillip Chief Medical Officer
Sold, plan not stated 2×
$619.12K 12,500 at 49.53
44.2%
14 Jul 2020
Virgin Herbert EVP, Research & CSO
Sold, plan not stated
$385.88K 7,900 at 48.85
100%
Sold half or more
13 Jul 2020
Sold, plan not stated
$1.50M 30,000 at 50.06
14.4%
2 Jul 2020
Sold, plan not stated
$400.00K 10,000 at 40.00
4.6%
1 Jul 2020
Parrish Jay Chief Business Officer
Sold, plan not stated
$2.85M 75,000 at 37.95
25.2%
1 Jul 2020
Pang Phillip Chief Medical Officer
Sold, plan not stated 2×
$472.25K 12,500 at 37.78
44.2%
1 Jul 2020
Sold, plan not stated 3×
$378.40K 10,000 at 37.84
4.4%
25 Jun 2020
Sold, plan not stated
$1.50M 30,000 at 50.00
11.6%
24 Jun 2020
Virgin Herbert EVP, Research & CSO
Sold, plan not stated
$449.28K 9,360 at 48.00
100%
Sold half or more
23 Jun 2020
Virgin Herbert EVP, Research & CSO
Sold, plan not stated
$216.78K 5,560 at 38.99
100%
Sold half or more
19 Jun 2020
Sold, plan not stated
$400.00K 10,000 at 40.00
3.7%
19 Jun 2020
Virgin Herbert EVP, Research & CSO
Sold, plan not stated 2×
$133.38K 3,510 at 38.00
100%
Sold half or more
17 Jun 2020
Pang Phillip Chief Medical Officer
Sold, plan not stated 2×
$465.81K 12,500 at 37.27
44.2%
9 Jun 2020
Virgin Herbert EVP, Research & CSO
Sold, plan not stated
$138.03K 3,805 at 36.28
100%
Sold half or more
3 Jun 2020
Pang Phillip Chief Medical Officer
Sold, plan not stated 2×
$438.39K 12,500 at 35.07
44.2%
1 Jun 2020
Parrish Jay Chief Business Officer
Sold, plan not stated
$2.64M 75,000 at 35.22
25.2%
1 Jun 2020
Sold, plan not stated 2×
$351.04K 10,000 at 35.10
3.6%
26 May 2020
Virgin Herbert EVP, Research & CSO
Sold, plan not stated
$129.67K 3,805 at 34.08
100%
Sold half or more
18 May 2020
Virgin Herbert EVP, Research & CSO
Sold, plan not stated
$66.69K 1,755 at 38.00
100%
Sold half or more
14 May 2020
Parrish Jay Chief Business Officer
Sold, plan not stated
$2.25M 75,000 at 30.05
25.2%
14 May 2020
Virgin Herbert EVP, Research & CSO
Sold, plan not stated
$114.42K 3,805 at 30.07
100%
Sold half or more
1 May 2020
MORE ROBERT J Director
Sold, plan not stated 2×
$516.85K 18,458 at 28.00
20.5%
16 Oct 2019
Bought
$30.00M 1,500,000 at 20.00
37.0%
First buy on file
16 Oct 2019
Burow Kristina Director · indirect
Bought
$20.00M 1,000,000 at 20.00
opened
First buy on file
16 Oct 2019
NELSEN ROBERT Director · indirect
Bought
$20.00M 1,000,000 at 20.00
opened
First buy on file
16 Oct 2019
ARCH Venture Partners IX, LLC 10% owner · indirect
Bought
$20.00M 1,000,000 at 20.00
opened
First buy on file
16 Oct 2019
Bought
$20.00M 1,000,000 at 20.00
37.5%
First buy on file
16 Oct 2019
SVF Endurance (Cayman) Ltd 10% owner · indirect
Bought
$19.00M 950,000 at 20.00
4.4%
First buy on file
16 Oct 2019
Temasek Holdings (Private) Ltd 10% owner · indirect
Bought
$10.00M 500,000 at 20.00
10.0%
First buy on file
Showing 301–344 of 344. ← Newer Page 7 of 7